Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06. | Haematologica | 2021 | 32855275 | PubTator, text mining | PubMed |
| Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma. | Haematologica | 2021 | 32817292 | PubTator, text mining | PubMed |
| Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21). | Pediatr Hematol Oncol | 2021 | 32803999 | PubTator, text mining | PubMed |
| RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses. | Leukemia | 2021 | 32782381 | PubTator, text mining | PubMed |
| Lymph node involvement by enteropathy-like indolent NK-cell proliferation. | Virchows Arch | 2021 | 32696224 | PubTator, text mining | PubMed |
| Crucial Functions of the JMJD1/KDM3 Epigenetic Regulators in Cancer. | Mol Cancer Res | 2021 | 32605929 | PubTator, text mining | PubMed |
| RUNX1T1 rs34269950 is associated with obesity and metabolic syndrome. | QJM | 2021 | 32589708 | PubTator, text mining | PubMed |
| Benzene induces rapid leukemic transformation after prolonged hematotoxicity in a murine model. | Leukemia | 2021 | 32503976 | PubTator, text mining | PubMed |
| PARP goes the weasel! Emerging role of PARP inhibitors in acute leukemias. | Blood Rev | 2021 | 32482307 | PubTator, text mining | PubMed |
| Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells. | Leukemia | 2021 | 32398790 | PubTator, text mining | PubMed |
| Epidemiological evaluation and survival of children with acute myeloid leukemia. | J Pediatr (Rio J) | 2021 | 32325011 | PubTator, text mining | PubMed |
| RUNX1-EVI1 disrupts lineage determination and the cell cycle by interfering with RUNX1 and EVI1 driven gene regulatory networks. | Haematologica | 2021 | 32299907 | PubTator, text mining | PubMed |
| Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia. | Haematologica | 2021 | 32139432 | PubTator, text mining | PubMed |
| Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing. | Leukemia | 2021 | 32127641 | PubTator, text mining | PubMed |
| Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia. | Haematologica | 2021 | 31896684 | PubTator, text mining | PubMed |
| Mesoscopic open-eye core-shell spheroid carved anode/cathode electrodes for fully reversible and dynamic lithium-ion battery models. | Nanoscale Adv | 2020 | 36134271 | PubTator, text mining | PubMed |
| Targeting transcription factors in cancer drug discovery. | Explor Target Antitumor Ther | 2020 | 36046384 | PubTator, text mining | PubMed |
| Myelodysplastic syndrome with clonal karyotype evolution associated with trisomy 8 and ASXL1 mutation in well-controlled HIV patient: Case report and literature review. | EJHaem | 2020 | 35847703 | PubTator, text mining | PubMed |
| PD1 expression on bone marrow T-cells in newly diagnosed Egyptian AML patients: Correlation with hematological parameters, aberrant antigens expression, and response to induction therapy. | EJHaem | 2020 | 35847700 | PubTator, text mining | PubMed |
| Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia. | EJHaem | 2020 | 35847688 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=69